Why is OpenAI's new video app generating violent content?
How did the US fall behind in the electric car race?
What impact will QatarEnergy's Egypt deal have?
Why did Rite Aid close all its stores?
How will Japan's new leader affect economic policy?
What caused the recent surge in Bitcoin prices?
How will government shutdown affect Fed rate decisions?
BridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart Condition
benzinga.com/news/health-care/25/09/47918744/bridgebios-acoramidis-cuts-risk-within-weeks-in-rare-heart-condition
BridgeBio Pharma, Inc. (NASDAQ: BBIO) on Sunday presented data from the ATTRibute-CM study.
The study showed that acoramidis reduced cumulative cardiovascular outcomes, including cardiovascular mortality (CVM) or recurrent cardiovascular-related hospitalizations (CVH), within the first…
This story appeared on benzinga.com, 2025-09-29 14:42:14.